Literature DB >> 14610320

Prospective evaluation of squamous cell carcinoma and carcinoembryonic antigen as prognostic factors in patients with cervical cancer.

Rafael Molina1, Xavier Filella, Jose A Lejarcegui, Jaime Pahisa, Aurelio Torné, Angels Rovirosa, Begoña Mellado, Jaume Ordi, Luis M Puig-Tintore, Julian Alicarte, Alberto Biete, Javier Iglesias.   

Abstract

Carcinoembryonic antigen (CEA) and squamous cell carcinoma(SCC) serum levels were prospectively determined in 159 untreated patients diagnosed with carcinoma of the uterine cervix from 1991 to 2001. The histological analysis showed epidermoid cancer in 117 patients, adenocarcinoma in 26 patients, adenosquamous carcinoma in 12 patients and other histological types in the remaining 4 patients. Tumor marker sensitivity was related to the histological type with abnormal SCC (>2 ng/ml) in 51.3% of squamous tumors in contrast to the 7.1% found in other histologies. By contrast, CEA sensitivity was not related to histology with abnormal values (>5 ng/ml) in 25% of squamous tumors, 19% of adenocarcinomas, 33% of adenosquamous carcinomas and 25% of other histologies. CEA and SCC serum levels were clearly related to tumor stage, parametrial invasion, tumor size and nodal involvement. Elevated pretreatment CEA indicates parametrial invasion with a probability of 82%. Likewise, pretreatment CEA and SCC serum levels were of prognostic value, with a shorter disease-free survival and overall survival in patients with abnormal levels. All patients with adenocarcinomas and abnormal CEA had relapse during follow-up. Multivariate analysis indicated that parametrial invasion, age, tumor size and SCC were independent prognostic factors. In conclusion, CEA and SCC are useful tumor markers in carcinomas of the uterine cervix, with a clear relationship with well-known prognostic factors (parametrial invasion, nodal involvement), and are of prognostic value. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14610320     DOI: 10.1159/000073846

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  9 in total

1.  Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site.

Authors:  Rafael Molina; Xavier Bosch; Josep M Auge; Xavier Filella; José M Escudero; Víctor Molina; Manel Solé; Alfonso López-Soto
Journal:  Tumour Biol       Date:  2011-12-09

2.  Clinical significance of tumor volume and lymph node involvement assessed by MRI in stage IIB cervical cancer patients treated with concurrent chemoradiation therapy.

Authors:  Dae Woo Lee; Young Tae Kim; Jae Hoon Kim; Sunghoon Kim; Sang Wun Kim; Eun Ji Nam; Jae Wook Kim
Journal:  J Gynecol Oncol       Date:  2010-03-31       Impact factor: 4.401

3.  Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix: comparison with serum SCCA, CYFRA21-1, and CEA levels.

Authors:  Xiugui Sheng; Xuelian Du; Xiaoling Zhang; Dapeng Li; Chunhua Lu; Qinshui Li; Zhifang Ma; Quqing Song; Cong Wang
Journal:  Croat Med J       Date:  2009-10       Impact factor: 1.351

4.  Clinical significance of Wnt-11 and squamous cell carcinoma antigen expression in cervical cancer.

Authors:  Heng Wei; Ning Wang; Yao Zhang; Shizhuo Wang; Xiaoao Pang; Jing Zhang; Qingshuang Luo; Youbo Su; Shulan Zhang
Journal:  Med Oncol       Date:  2014-04-16       Impact factor: 3.064

5.  The prognostic value of squamous cell carcinoma antigen for predicting tumor recurrence in cervical squamous cell carcinoma patients.

Authors:  Hyun Kyung Ryu; Ji Sun Baek; Woo Dae Kang; Seok Mo Kim
Journal:  Obstet Gynecol Sci       Date:  2015-09-22

6.  GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer.

Authors:  Fei Ouyang; Junling Liu; Meng Xia; Chuyong Lin; Xianqiu Wu; Liping Ye; Libing Song; Jun Li; Jing Wang; Peng Guo; Mian He
Journal:  Oncol Rep       Date:  2017-04-11       Impact factor: 3.906

7.  Prognostic Role of Squamous Cell Carcinoma Antigen in Cervical Cancer: A Meta-analysis.

Authors:  Zhenhua Liu; Hongtai Shi
Journal:  Dis Markers       Date:  2019-06-02       Impact factor: 3.434

8.  Risk Factors of Regional Lymph Node Metastasis in Patients with Cervical Cancer.

Authors:  Chunchun Wu; Lichun Li; Xue Xiao; Anyi Sun; Wenji Lin; Ailu Li
Journal:  Open Life Sci       Date:  2019-06-24       Impact factor: 0.938

9.  The role of squamous cell carcinoma antigen as a prognostic and predictive factor in carcinoma of uterine cervix.

Authors:  Bae Kwon Jeong; Doo Ho Choi; Seung Jae Huh; Won Park; Duk Soo Bae; Byoung-Gie Kim
Journal:  Radiat Oncol J       Date:  2011-09-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.